Metal Nanoparticles (eBook)

Synthesis and Applications in Pharmaceutical Sciences

Sreekanth Thota, Debbie C. Crans (Herausgeber)

eBook Download: EPUB

2017 | 1. Auflage
300 Seiten
Wiley-VCH (Verlag)
978-3-527-80708-6 (ISBN)

Infos

A much-needed summary of the importance, synthesis and applications of metal nanoparticles in pharmaceutical sciences, with a focus on gold, silver, copper and platinum nanoparticles. After a brief introduction to the history of metal complexes in medicine and fundamentals of nanotechnology, the chapters continue to describe different methods for preparation of metal nanoparticles. This section is followed by representative presentations of current biomedical applications, such as drug delivery, chemotherapy, and diagnostic imaging.
Aimed at stimulating further research in this field, the book serves as an reference guide for academics and professionals working in the field of chemistry and nanotechnology.


Sreekanth Thota is a Visiting Researcher at the Center for Technological Development in Health, Fundac?o Oswaldo Cruz - Fiocruz in Rio de Janeiro, Brazil. He studied Pharmaceutical Chemistry at Kakatiya University (India) and Rajiv Gandhi University of Health Sciences (Bangalore, India) and obtained his Ph.D from Jawaharlal Nehru Technological University Hyderabad (India) in 2011. He then did postdoctoral work at Colorado State University, USA. He received the 2013 CAPES-Fiocruz, Visiting Researcher award and has published over 40 articles in peer-reviewed journals. His research interest is focused on the drug discovery, medicinal chemistry, fundamental chemistry and biochemistry of ruthenium and other transition metal ions leading to applications in medicine.

Debbie C. Crans is Professor of Organic and Inorganic Chemistry and in the Cell and Molecular Biology Program at Colorado State University, Fort Collins, USA. She obtained her Ph.D. in Chemistry from Harvard University with George M. Whitesides, USA, in 1985. She did a postdoctoral fellowship with Orville L. Chapman and Paul D. Boyer at UCLA in 1986. Her research interests lie in biological chemistry with expertise in metals in medicine and coordination chemistry with a focus on transition metals such as vanadium and platinum and interests in membrane model systems and hydrophobic compounds and lipids such as menaquinone. She received the Vanadis Award in 2004 and in the 2015 Cope Scholar Award. She has published over 190 articles in peer-reviewed journals.

Autor

Sreekanth Thota is a Visiting Researcher at the Center for Technological Development in Health, Fundação Oswaldo Cruz - Fiocruz in Rio de Janeiro, Brazil. He studied Pharmaceutical Chemistry at Kakatiya University (India) and Rajiv Gandhi University of Health Sciences (Bangalore, India) and obtained his Ph.D from Jawaharlal Nehru Technological University Hyderabad (India) in 2011. He then did postdoctoral work at Colorado State University, USA. He received the 2013 CAPES-Fiocruz, Visiting Researcher award and has published over 40 articles in peer-reviewed journals. His research interest is focused on the drug discovery, medicinal chemistry, fundamental chemistry and biochemistry of ruthenium and other transition metal ions leading to applications in medicine. Debbie C. Crans is Professor of Organic and Inorganic Chemistry and in the Cell and Molecular Biology Program at Colorado State University, Fort Collins, USA. She obtained her Ph.D. in Chemistry from Harvard University with George M. Whitesides, USA, in 1985. She did a postdoctoral fellowship with Orville L. Chapman and Paul D. Boyer at UCLA in 1986. Her research interests lie in biological chemistry with expertise in metals in medicine and coordination chemistry with a focus on transition metals such as vanadium and platinum and interests in membrane model systems and hydrophobic compounds and lipids such as menaquinone. She received the Vanadis Award in 2004 and in the 2015 Cope Scholar Award. She has published over 190 articles in peer-reviewed journals.

Inhalt

1) Introduction: History of Metal Complexes, Nanotechnology, Nanoparticles
2) Methods for Preparation of Metal Nanoparticles
3) Metal Nanoparticles as Therapeutic Agents: A Paradigm-Shift in Medicine
4) Nanoparticles for Imaging
5) Soft-Oxometalates: A New State of Oxometalates and their Potential Applications as Nanomotors
6) Medicinal Application of Metal Nanoparticles and Complexes
7) Metal Nanoparticles in Nanomedicine: Advantages and Scopes
8) Metal Nanoparticles as Anticancer Agents
9) Noble Metal Nanoparticles and their Antimicrobial Properties
10) Metal Nanoparticles and their Toxicity

Textauszug

Chapter 1
Introduction

Sreekanth Thota1,2,3 and Debbie C. Crans3

1Fundação Oswaldo Cruz – Ministério da Saúde, National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Av. Brazil 4036 – Prédio da Expansão, 8 Andar – Sala 814, Manguinhos, Rio de Janeiro, 21040-361, Brazil

2Universidade Federal do Rio de Janeiro, Programa de Desenvolvimento de Fármacos, Instituto de Ciências Biomédicas, Av. Carlos Chagas Filho, Rio de Janeiro, RJ, 21941-902, Brazil

3Colorado State University, Department of Chemistry, Fort Collins, Colorado, 80523, USA

1.1 History of Metal Complexes

1.1.1 Introduction

Pharmaceutical science, which studies the design, action, delivery, and disposition of drugs, is an important field in drug research. Humans have made several sincere attempts for the search of new drugs in order to cure and control different diseases. Although possible remedial measures are available at present to tackle any disease, scientists are increasingly trying to find superior and more effective drugs [1]. Over the last 50 years some “wonder drugs” have played a crucial role in diminishing the global burden of infectious diseases. New drugs are constantly being screened for their potential biological properties. Among the category of new drugs that are receiving much attention are metal-based drugs [2]. Precious metals have been used for medicinal purposes for at least 3500 years. Among them, gold has played a crucial role in a variety of medicines in China and Arabia [3].

1.1.2 Metal Complexes

Medicinal inorganic chemistry is in the early days of its development, although there are now a significant number of clinical trials involving metal compounds or other agents that interfere with metabolic pathways for metals, both for therapy and for diagnosis [4]. In chemistry, metal complexes are nothing but reactions between metals and ligands [5]. Biomedical applications of several metal coordination compounds in recent years have provided a substantial contribution to the augmentation of more impressive diagnostic and therapeutic agents [6]. Metal coordination compounds and metal ions are known to effect cellular processes in a dramatic way [7]. Metal coordination complexes offer biological and chemical diversity that is distinct from that of organic drugs.

1.1.3 Metal Complexes in Medicine

In the ancient history of medicine, extraordinarily, many metal-based drugs played a crucial role as anti-infective agents. The increasing medicinal application of metals and metal complexes day by day is gaining clinical and commercial significance [8]. The development of metals containing anticancer drugs has been in the 1960s with the synthesis of Platinum compounds. Cisplatin is one of the most extensively used antineoplastic drugs, specifically for the treatment of ovarian and testicular cancers [9, 10]. The success of cisplatin and its analogs has accelerated a resurgence of inorganic medicinal chemistry and the search for complexes of other precious metals [Ru, Va, Zn, Cu, Ag, Gold, Pd] with interesting biological properties [11–17]. Among them, particularly ruthenium compounds have attracted significant attention with two compounds, namely, NAMI-A and KP1019, advancing through clinical trials [18]. Many precious metals and metal compounds have succeeded in the clinic over the last few decades. Platinum compounds are the most extensively used chemotherapeutic agents, silver compounds have been useful as antimicrobial agents, and gold compounds are used widely in the treatment of rheumatoid arthritis. Scientists have been investigating over the past 25 years several metal-based compounds and such return of interest in metal-based drugs can be witnessed in several recent articles [19–24].

1.2 Nanotechnology

1.2.1 Introduction

In today's world, nanotechnology is a relatively new field, but its structural nanometer dimensions and functional devices are not new, and in fact, these materials have much significance. In recent years, we found a plethora of literature explaining the recent advances in nanotechnology [25–33]. Nanotechnology has the potential to provide novel, paradigm-shifting solutions to medical problems. Nanotechnology, which has been defined as the engineering and manufacturing of materials at the atomic and molecular scale, offers exclusive tools for developing safer and more efficient medicines (nanomedicines), and provides several potential advantages in drug formulation and delivery. Nanotechnology refers to an emerging field of science that includes preparation and development of various nanomaterials. Nowadays, nanomaterials are widely used in many fields including biomedicine, consumer goods, and energy production [34–37]. The purpose of nanomaterials in biotechnology combines the fields of material science and biology.

1.2.2 Development of Nanotechnology

In recent years, disparate products of nanotechnology have played a key role in adding a novel armamentarium of therapeutics to the pipelines of pharmaceutical industries. The nanotechnology fever we are experiencing now began when the United States launched the National Nanotechnology Initiative [38], the world's first program of its kind, in 2000. Nanotechnology usage may possibly achieve many advantages: (i) improved delivery of poorly water-soluble drugs; (ii) targeted delivery of drugs in a cell- or tissue-specific manner; (iii) drugs transcytosis beyond the tight endothelial and epithelial barriers; (iv) improved delivery of large macromolecule drugs to intracellular sites of action; (v) co-delivery of multiple drugs or therapeutic modality for combination therapy; (vi) improvement in drug delivery through visualization of sites by combining therapeutic agents with imaging modalities [39]; and (vii) real-time read on the in vivo efficacy of an agent [40]. Nanotherapeutics has the potential to actively target tumors, increasing the therapeutic effectiveness of a treatment while limiting side effects. This improved therapeutic index is one of the great promises of nanotechnology [41].

1.2.3 Nanotechnology in Medicine

In pharmaceutical trade, a new molecular entity (NME) that exhibits significant biological activity but meager water solubility, or a very terse circulating half-life, will likely face significant challenges in progress or will be assumed undevelopable [42]. Nanotechnology may revolutionize the rules and possibilities of drug discovery and change the landscape of pharmaceutical industries. In medicine, nanotechnology application may be referred to as nanomedicine that explains various intriguing possibilities in the healthcare sector. The major current and promising applications of nanomedicine include, but are not limited to, drug delivery, in vivo imaging, in vitro diagnostics, biomaterials, therapy techniques, and tissue engineering [28]. In oncology, nanomaterials can enable targeted delivery of imaging agents and therapeutics to cancerous tissues; nanoscale devices enable multiplexed sensing for early disease detection and therapeutic monitoring. The drug delivery field application of nanotechnology is widely expected to change the landscape of pharmaceutical and biotechnology industries in the foreseeable future [40, 43–45]. Nanotechnology attracts scientists because of a wide variety of applications, which includes drugs and medicines, energy, nanoparticles, nanodevices, nanobiotechnology, optical engineering, bioengineering, nanofabrics, and cosmetics (Figure 1.1).

Figure 1.1 Applications of Nanotechnology.

1.3 Nanoparticles

1.3.1 Introduction

Any intentionally produced particle that has a characteristic dimension from 1 to 100 nm and has properties that are not shared by non-nanoscale particles with the same chemical composition has been called a nanoparticle [46, 47]. Nanoparticles demonstrate a particularly useful platform, describing exclusive properties with potentially wide-ranging therapeutic applications [48]. The enormous diversity of nanoparticles was described (Figure 1.2). Nanoparticles made of polymers (NPs) are of particular interest as drug delivery systems because of their synthetic versatility as well as their tunable properties (e.g., thermosensitivity and pH response). Nanoparticles offer exciting prospects for improving delivery, cell uptake, and targeting of metallodrugs, especially anticancer drugs, to make them more effective and safer. Transition metal nanoparticles synthesis has been extensively investigated in recent years because of its many unique physical (electronic, magnetic, mechanical, and optical) and chemical properties. Nanoparticles are often in the range 10–100 nm and this is the same size as that of human proteins.

Figure 1.2 Various features of engineered nanoparticles.

1.3.2 Development of Nanoparticles

The primary intention in designing nanoparticles as a delivery system is to manage particle size, surface properties, and release of pharmacologically active agents in order to obtain the site-specific action of the drug at the therapeutically optimal rate and dose regimen [49]. Nanoscale particles developed using organic molecules as building blocks have been widely examined for drug and gene delivery. For example, polymer, polymersome, and liposome constructs for controlled release of proteins and polymeric micelles,...

Produkt-Details

• Erscheint lt. Verlag: 20.12.2017
• Sprache: englisch
• Themenwelt: Naturwissenschaften ► Chemie
• Schlagworte: Anorganische Chemie • Chemie • Chemistry • Industrial Chemistry • Inorganic Chemistry • Nanomaterial • Nanomaterialien • nanomaterials • Nanotechnologie • nanotechnology • Pharmaceutical & Medicinal Chemistry • Pharmazeutische Chemie • Pharmazeutische u. Medizinische Chemie • Technische u. Industrielle Chemie
• ISBN-10: 3-527-80708-X / 352780708X
• ISBN-13: 978-3-527-80708-6 / 9783527807086